💥🇺🇸#SAVA Cassava Sciences - хорошие данные по препарату Simufilam при болезни Альцгеймера top-line results of 12-month interim analysis from open-label study evaluating Simufilam in Alzheimer’s Disease; - Cognition Scores Improved 3.2 Points on ADAS-Cog…